Contributor: By loosening standards, the FDA isn’t doing rare-disease patients any favors

It’s reasonable to assess rare-disease drugs differently. That’s why the FDA has been remarkably flexible about these ...

A CT man pushing for a diagnosis got a devastating one. Then he learned of ‘amazing breakthroughs’

Lee Ross knew there was a problem when he was starting to search for words, or couldn’t finish a sentence. He was right. Ross ...